logo

OCTOBER 29-NOVEMBER 2, 2017
COLORADO CONVENTION CENTER
DENVER, COLORADO

Satellite programs offer sponsors the opportunity to provide professional attendees with comprehensive insights into important interventional topics and issues facing today's specialists. The satellite program schedule is comprised of Breakfast Meetings, Presentation Theater Programs (lunch sessions), and Evening Programs.

 

Satellite Programs

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibition after PCI

Evening Program

10/30/2016 18:30:00 10/30/2016 20:00:00 A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibition after PCI TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Evening Program

Sunday, October 30, 2016
Reception: 6:00 pm  | 
Program: 6:30 pm-8:00 pm
Marriott Marquis Washington, DC., Marquis Ballroom, Salon 1-4

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibition after PCI

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibition after PCI

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Chiesi USA

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Chairs  

Gregg W. Stone, MD

New York-Presbyterian Hospital/Columbia University Medical Center

New York, NY

 

Harvey D. White, DSc

Auckland City Hospital Greenlane Cardiovascular Services

Auckland, New Zealand

Faculty  

Dominick J. Angiolillo, MD, PhD

University of Florida

Jacksonville, FL

 

Deepak L. Bhatt, MD, MPH

Brigham and Women's Hospital

Boston, MA

 

Philippe Genereux, MD

Columbia University Medical Center/Hôpital du Sacré-Coeur de Montréal

New York, NY

 

C. Michael Gibson, MD, MS

Beth Israel Deaconess Medical Center

Boston, MA

 

Christian W. Hamm, MD

Kerckhoff Clinic

Bad Nauheim, Germany

 

Robert A. Harrington, MD

Stanford University School of Medicine

Stanford, CA

Agenda

6:30 pm

Is Oral Agent Preloading Before PCI Safe or Effective? Theory and Evidence

C. Michael Gibson

6:40 pm

Roundtable Discussion with Audience Q&A

6:45 pm

Outcomes of Establishing Potent P2Y12 Receptor Inhibition with Intravenous Cangrelor: Lessons From the PHOENIX and the CHAMPION Trials

Robert A. Harrington

6:55 pm

Roundtable Discussion with Audience Q&A

7:00 pm

Intra-Procedural Stent Thrombosis: What Is It; Why Should We Care; and How Can We Prevent It?

Philippe Genereux

7:10 pm

Roundtable Discussion with Audience Q&A

7:15 pm

Transitioning From Oral to Intravenous P2Y12 Receptor Blockade, and From Intravenous to Oral P2Y12 Receptor Blockade: What the Practitioner Needs to Know

Dominick J. Angiolillo

7:25 pm

Roundtable Discussion with Audience Q&A

7:30 pm

Patient Selection and Adjunct Pharmacology for Potent Intravenous Platelet Inhibition: Practical Considerations

Deepak L. Bhatt

7:40 pm

Roundtable Discussion With Audience Q&A

7:45 pm

Case Reviews: Anti-platelet Agent Decision Making

Christian W. Hamm

8:00 pm

Adjourn